Applying Machine Learning Techniques for Classifying Cyclin-Dependent Kinase Inhibitors

The importance of protein kinases made them a target for many drug design studies. They play an essential role in cell cycle development and many other biological processes. Kinases are divided into different subfamilies according to the type and mode of their enzymatic activity. Computational studies targeting kinase inhibitors identification is widely considered for modelling kinase-inhibitor. This modelling is expected to help in solving the selectivity problem arising from the high similarity between kinases and their binding profiles. In this study, we explore the ability of two machine-learning techniques in classifying compounds as inhibitors or non-inhibitors for two members of the cyclin-dependent kinases as a subfamily of protein kinases. Random forest and genetic programming were used to classify CDK5 and CDK2 kinases inhibitors. This classification is based on calculated values of chemical descriptors. In addition, the response of the classifiers to adding prior information about compounds promiscuity was investigated. The results from each classifier for the datasets were analyzed by calculating different accuracy measures and metrics. Confusion matrices, accuracy, ROC curves, AUC values, F1 scores, and Matthews correlation, were obtained for the outputs. The analysis of these accuracy measures showed a better performance for the RF classifier in most of the cases. In addition, the results show that promiscuity information improves the classification accuracy, but its significant effect was notably clear with GP classifiers.

[1]  Stefan Kramer,et al.  Predicting a small molecule-kinase interaction map: A machine learning approach , 2011, J. Cheminformatics.

[2]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[3]  Hwa Jen Yap,et al.  A genetic programming approach to oral cancer prognosis , 2016, PeerJ.

[4]  A. Arif Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. , 2012, Biochemical pharmacology.

[5]  N. Ip,et al.  Cdk5: a multifaceted kinase in neurodegenerative diseases. , 2012, Trends in cell biology.

[6]  K. No,et al.  Descriptor-Based Profile Analysis of Kinase Inhibitors to Predict Inhibitory Activity and to Grasp Kinase Selectivity , 2013 .

[7]  Juho Rousu,et al.  Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors , 2017, PLoS Comput. Biol..

[8]  W. Taylor,et al.  Targeting the Cell Cycle to Kill Cancer Cells , 2009 .

[9]  M. Malumbres,et al.  Cyclin-dependent kinases , 2014, Genome Biology.

[10]  J. Bajorath,et al.  Current compound coverage of the kinome. , 2015, Journal of medicinal chemistry.

[11]  Igor V. Tetko,et al.  Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..

[12]  Moshe Sipper,et al.  Software review: the HeuristicLab framework , 2014, Genetic Programming and Evolvable Machines.

[13]  Thomas G. Dietterich What is machine learning? , 2020, Archives of Disease in Childhood.

[14]  A. Valencia,et al.  KinMutRF: a random forest classifier of sequence variants in the human protein kinase superfamily , 2016, BMC Genomics.

[15]  Khaled Rasheed,et al.  Classifying kinase conformations using a machine learning approach , 2017, BMC Bioinformatics.

[16]  P. Hajduk,et al.  Navigating the kinome. , 2011, Nature chemical biology.

[17]  Potential mechanistic profiling of an otc analgesic as a cytotoxic agent in the treatment of hepatocellular carcinoma , 2018 .

[18]  Anne-Laure Boulesteix,et al.  Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics , 2012, WIREs Data Mining Knowl. Discov..